Releasing the Brakes on the Immune System
Learn MoreImmune checkpoint inhibitors are transformative new immunotherapeutics that can unleash the body’s immune system to attack and destroy cancer cells.
Progress Across the Clinical Cancer Care Continuum
In the United States, the overall cancer death rate is declining steadily, and more individuals are living longer and fuller lives after a cancer diagnosis.
Learn MoreProgress in Molecularly Targeted Therapy
Research-driven advances in identifying genetic mutations that fuel tumor growth have set the stage for a new era of precision medicine.
Learn MoreReducing the Risk of Cancer Development
In the United States, 40 percent of all cancers are associated with modifiable risk factors.
Learn More
